Clinical Trial Details
EORTC-55985
Back to Clinical Trials Database
PHASE II CLINICAL TRIAL ON TAXOL AS SINGLE AGENT IN LOCALLY ADVANCED AND/OR METASTATIC OR RECURRENT VULVA CANCER NOT AMENABLE FOR SURGERY AND/OR RADIOTHERAPY - EORTC trial 55985
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 07-Feb-2001 Date Step1 close: 18-Feb-2005 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 29 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00014599 |
NCT number | NCT00014599 |